Vavricka John
Insider CIK 1829630 · AVIR Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 33,333 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 119,520 | — | $0 | 119,520 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 8,750 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-01-31 | 2026-02-03 | 42,083 | — | $0 | 94,164 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2026-01-31 | 2026-02-03 | 11,570 | $4.24 | $49.1K | 82,594 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 8,750 | — | $0 | 8,750 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 132,800 | — | $0 | 132,800 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 33,333 | — | $0 | 33,333 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2025-01-31 | 2025-02-04 | 11,517 | $3.06 | $35.2K | 52,081 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 33,333 | — | $0 | 54,848 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award | 2025-01-31 | 2025-02-04 | 8,750 | — | $0 | 63,598 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 11,819 | $3.84 | $45.4K | 21,515 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 33,334 | — | $0 | 66,666 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 132,800 | — | $0 | 132,800 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 33,334 | — | $0 | 33,334 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 135,000 | — | $0 | 135,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 117,300 | — | $0 | 117,300 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion deriv | 2020-11-03 | 2020-11-03 | 82,508 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | C Conversion | 2020-11-03 | 2020-11-03 | 82,508 | — | $0 | 82,508 | SEC↗ |